Lanzamiento Enero 2027

Ensayo controlado aleatorizado2002

Caffeine ingestion does not alter performance during a 100-km cycling time-trial performance

Hunter AM, St Clair Gibson A, Collins M, Lambert M, Noakes TD

International journal of sport nutrition and exercise metabolism · 35 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
University of Cape Town
Gobierno
Medical Research Council

Según 2 financiadores declarados.

Publicación

Publicado
2002-12-01 · Int J Sport Nutr Exerc Metab · vol. 12 · número 4 · págs. 438–452
Editorial
Human Kinetics
Citado
72 citas · más que el 84% de estudios similares · 1.7× el promedio de su campo
Referencias
48 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Coffee research and impacts · Sports Performance and Training · Muscle metabolism and nutrition
Palabras clave
caffeine ingestion, cycling time trial, high-intensity exercise, endurance performance, carbohydrate intake, heart rate, muscle EMG, mean power frequency, muscle fatigue, trained cyclists, caffeine tolerance, caffeine dose-response, caffeine side effects
MeSH
humans, lactic acid, caffeine, dietary carbohydrates, fatty acids, nonesterified, exercise test, electromyography, energy metabolism, oxygen consumption, heart rate, physical endurance, bicycling, adult, male

6 autores

  • Angus M. Hunter🇬🇧University of Stirling
  • Allan St🇿🇦University of Cape Town; Sports Science Institute of South Africa
  • Clair Gibson🇿🇦University of Cape Town; Sports Science Institute of South Africa
  • Malcolm Collins🇿🇦University of Cape Town; Sports Science Institute of South Africa
  • Mike Lambert🇿🇦University of Cape Town; Sports Science Institute of South Africa
  • Timothy David Noakes🇿🇦University of Cape Town

Resumen

El texto original del estudio, en el idioma en que se publicó.

This study analyzed the effect of caffeine ingestion on performance during a repeated-measures, 100-km, laboratory cycling time trial that included bouts of 1- and 4-km high intensity epochs (HIE). Eight highly trained cyclists participated in 3 separate trials' placebo ingestion before exercise with a placebo carbohydrate solution and placebo tablets during exercise (Pl), or placebo ingestion before exercise with a 7% carbohydrate drink and placebo tablets during exercise (Cho), or caffeine tablet ingestion before and during exercise with 7% carbohydrate (Caf). Placebo (twice) or 6 mg.kg(-1) caffeine was ingested 60 min prior to starting 1 of the 3 cycling trials, during which subjects ingested either additional placebos or a caffeine maintenance dose of 0.33 mg.kg(-1) every 15 min to trial completion. The 100-km time trial consisted of five 1-km HIE after 10, 32, 52, 72, and 99 km, as well as four 4-km HIE after 20, 40, 60, and 80 km. Subjects were instructed to complete the time trial and all HIE as fast as possible. Plasma (caffeine) was significantly higher during Caf (0.43 +/- 0.56 and 1.11 +/- 1.78 mM pre vs. post Pl; and 47.32 +/- 12.01 and 72.43 +/- 29.08 mM pre vs. post Caf). Average power, HIE time to completion, and 100-km time to completion were not different between trials. Mean heart rates during both the 1-km HIE (184.0 +/- 9.8 Caf; 177.0 +/- 5.8 Pl; 177.4 +/- 8.9 Cho) and 4-km HIE (181.7 +/- 5.7 Caf; 174.3 +/- 7.2 Pl; 175.6 +/- 7.6 Cho; p <.05) was higher in Caf than in the other groups. No significant differences were found between groups for either EMG amplitude (IEMG) or mean power frequency spectrum (MPFS). IEMG activity and performance were not different between groups but were both higher in the 1-km HIE, indicating the absence of peripheral fatigue and the presence of a centrally-regulated pacing strategy that is not altered by caffeine ingestion. Caffeine may be without ergogenic benefit during endurance exercise in which the athlete begins exercise with a defined, predetermined goal measured as speed or distance.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.